Desmopressin Acetate 0.2 mg Tablet

Adult dose

Treatment of nocturia associated with nocturnal polyuria (adults only) Administer desmopressin acetate 0.1mg orally at bedtime. If the effect is insufficient after one week, increase the dose to 0.2mg; if the effect remains insufficient, the dose may be increased at one-week intervals up to 0.4mg. Discontinue administration if there is no clinical effect within 4 weeks after dose determination. Initiation of treatment with this drug is not recommended in patients aged 65 years or older. In elderly patients who require treatment, closely monitor serum sodium levels and other parameters. (See 5. General Precautions under Precautions for Use.)

Child dose

Primary nocturnal enuresis (age 5 years and older): Administer 0.2mg of desmopressin acetate orally at bedtime. If the effect is insufficient, the dose may be increased to 0.4mg. Whether to continue treatment should be determined after 3 months of administration, with treatment withheld for at least 1 week.

This medication may cause hyponatremia and water intoxication, so particular caution is needed for the elderly and patients with certain conditions to avoid excessive water intake. This medication contains lactose, and should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. Patients with a history of hypersensitivity, or those with specific heart or kidney diseases, as well as those taking diuretics, should not use this medication. It should only be used in patients with normal blood pressure for the treatment of enuresis, and should not be administered to patients with moderate or severe renal failure or hyponatremia. Patients with hypertension, chronic kidney disease, women who may become pregnant, children and the elderly should use this medication with caution, and patients with fluid and electrolyte imbalances also require careful attention. While using this medication, symptoms related to water intoxication, such as headache, nausea, weight gain, and seizures, should be closely monitored, and if abnormal symptoms occur, administration should be discontinued immediately. Fluid intake should be restricted from 1 hour before administration to 8 hours after, and the restriction duration may vary based on kidney function, so it must be adhered to strictly. This medication can interact with various drugs, so if other medications are being taken, it is essential to consult with a doctor or pharmacist. Women who are pregnant or may become pregnant should use this medication cautiously, and it is recommended to discontinue breastfeeding if breastfeeding. In case of overdose, symptoms such as headaches, nausea, seizures, and altered consciousness may occur, so if symptoms are severe, immediate medical treatment is necessary. This medication does not affect the ability to drive or operate machinery; however, caution is required in case of side effects.

• unconsciousness
• seizures
• weight gain
• hyponatremia
• emotional disturbances
• headache
• abdominal pain
• nausea
• allergic skin reactions
• dizziness

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

White, convex, round tablets

Package unit

30 tablets/bottle